Clinical Trials Browser

Phase 1 × imgatuzumab × Head & Neck × Clear all

NCT01046266 2016-09-14

A Study of Pharmacodynamics of RO5083945 in Patients With Head and Neck Squamous Cell Carcinoma

Phase 1 Completed

Head and Neck Neoplasms